Thieme has launched Therapeutics NOW, a new gold open access journal focused on advancing evidence-based therapeutic development and accelerating the translation of research into patient care. The journal expands Thieme’s open access portfolio and is positioned to serve researchers working across therapeutic sciences, clinical research, and translational medicine.
Therapeutics NOW will publish research in areas including gene therapy, immunotherapy, drug discovery, targeted delivery systems, personalized medicine, and related fields. The journal is designed to connect experts from academia, industry, and clinical practice worldwide, with an emphasis on rapidly incorporating validated research findings into real-world healthcare applications. Authors benefit from fast, professional and efficient peer review processes to publish and disseminate their research open access.
The journal has been structured with an interdisciplinary scope that reflects the complexity of modern healthcare. Contributions are expected from disciplines such as chemistry, biology, engineering, clinical science, and policy, supporting systems-level approaches to therapeutic innovation. Each article includes a Research Significance Highlight to help readers quickly assess translational relevance beyond disciplinary boundaries.
To support rapid and rigorous dissemination, Therapeutics NOW uses Select Crowd Review (SCR), a peer review model intended to deliver a first editorial decision in less than one week after submission. The approach draws feedback from experts across multiple research areas to ensure quality, transparency, and visibility within the academic community while maintaining scientific integrity.
The journal accepts a wide range of article formats, including original research, review articles, industrial case studies, and policy and impact briefs. Subject areas span applied computational biology, drug discovery and development, biopharmaceuticals, theragnostics, synthetic biology, cancer biology, immunotherapy, preventive medicine, diagnostics, and biomedical engineering. Each article includes a significance or impact box to explain relevance to readers outside the specific field and to support multidisciplinary understanding.
Click here to read the original press release.
